Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial.
Cell Rep Med
; 4(12): 101307, 2023 12 19.
Article
in En
| MEDLINE
| ID: mdl-38056464
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antibodies, Monoclonal, Humanized
/
Neoplasms
Limits:
Humans
Language:
En
Journal:
Cell Rep Med
Year:
2023
Document type:
Article
Affiliation country:
Finland
Country of publication:
United States